
BIOSANBIO
HyaRelief™
A pre-filled syringe with highly purified sodium hyaluronate for intra-articular use and viscoelastic supplementation of synovial fluid.
Product details
SLOContact Orthopaedics·regenerative medicine
Remedica provides healthcare institutions and private clinics with carefully selected medical devices, professional product presentations and reliable support.
Remedica programme
Four clearly defined product programmes for healthcare institutions, private clinics and specialist practices, supported by personal professional guidance.

BIOSANBIO
A pre-filled syringe with highly purified sodium hyaluronate for intra-articular use and viscoelastic supplementation of synovial fluid.
Product details
PHIBIO GMBH
A combined intra-articular solution with sodium hyaluronate, N-acetylglucosamine and chondroitin sulphate.
Product details
D-MED
Standard pack for preparing an autologous plasma fraction rich in extracellular vesicles from the patient's own blood.
Programme details
D-MED
Complete solutions for the standardised preparation of platelet-rich plasma for professional clinical use.
Explore the programmeHow we work
We first learn about the field of work, clinical setting and the needs of the professional team.
Medically qualified staff present the product, documentation and correct workflow.
We provide reliable supply and remain available for further professional questions.
Regenerative medicine
D-MED combines T-LAB's development and professional heritage with solutions for preparing PRP and autologous extracellular vesicles. The programme is designed for healthcare professionals who value a controlled process, consistency and practical use.
Enquire about D-MEDD-MED · PRP programme
A programme for professional PRP preparation, from blood collection and centrifugation to the final sample. Contact the Remedica team for detailed protocols and configuration selection.

D-MED · CE CLASS IIb
A complete kit with mutually compatible components for standardised PRP preparation in a closed system. The protocol requires one centrifugation.

D-MED · CE CLASS IIb
The micro-polished inner surface reduces platelet adhesion and mechanical loss during processing. Closed system and single centrifugation.

D-MED · 10 ml
A dedicated 10 ml syringe that converts into a centrifuge tube after blood collection and then back into a syringe in two steps.
* Results from D-MED development laboratory analyses as stated by the manufacturer. Final results depend on the protocol and sample.
D-MED · autologous programme
EXOMAS Standard Pack is a standard pack for preparing an autologous plasma fraction rich in extracellular vesicles from the patient's own blood. The protocol combines PRP preparation, controlled mechanical processing with the Cellitium 600 μm processor and separation in new-generation PRX tubes.
For trained physicians only. The procedure, patient selection, indications and application must comply with current instructions for use and professional and regulatory requirements.
Professional programme presentation
D-MED · supporting instrument
The centrifuge is a supporting instrument for regenerative protocols and is not a standalone Remedica sales programme. It is presented last as additional equipment for professional use.

Selected scientific publications
The selection prioritises recent clinical, comparative and randomised research and also includes clearly identified preclinical work. The summaries do not constitute treatment recommendations.
A sham-controlled trial compared three groups of patients with lateral epicondylitis. After 12 weeks, the combination of PRP, shock-wave therapy and exercise achieved better clinical outcomes for pain, function and grip strength; ultrasonographic parameters did not differ between the groups.
Archives of Physical Medicine and Rehabilitation · DOIA skeletal-muscle injury model in 28 rabbits directly compared Exomine®, T‑LAB PRP®, Arthrex ACP® and a control group. T‑LAB and Arthrex achieved comparable, approximately 2.5- to 3-fold platelet enrichment with no statistically significant difference. Exomine showed a more favourable histological profile of inflammation and scarring, but the results are preclinical and require clinical confirmation.
Acta Orthopaedica Belgica · DOIThree groups compared PRP, supervised exercise and their combination in mild to moderate knee osteoarthritis. The registered randomised study monitored pain and function.
Clinical Orthopaedics and Related Research · DOIIn 62 patients with knee osteoarthritis, preparation with the T‑LAB system achieved a dose of 3.25 billion platelets, 77% recovery and 98.4% PRP purity (DEPA classification B-B-A). The study also analysed the influence of baseline platelet count and individual factors.
Acta Orthopaedica et Traumatologica Turcica · DOIThe cohort study compared pain and function after four approaches in grade 2–3 osteoarthritis. The authors emphasise the retrospective design and individual clinical judgement.
Medicine · DOIIn 40 patients with chronic shoulder pain, ultrasound-guided PRP and cortisone injections were compared. Both groups improved in pain and function at one and two months; pain reduction at two months was greater in the PRP group.
Turkish Journal of Osteoporosis · DOIFull texts are held in Remedica's professional archive. External links lead to publisher records or directly to DOI addresses; access may depend on the publisher's policy.
BiosanBio · HA injections
HyaRelief™ is a line of medical devices for intra-articular use in symptoms of osteoarthritis. The standard line comprises seven variants from 20 to 90 mg, with concentrations from 1.0 to 3.0% and volumes from 2 to 3 ml. It is intended for viscoelastic supplementation or replacement of synovial fluid in the joint.
An open-label phase IV study followed 90 patients with grade III knee osteoarthritis after one application. VAS and WOMAC outcomes improved significantly from baseline at all follow-up points; adverse events in 5.6% of participants were mild and transient. The study had no control group.
Open publicationHyaRelief · standard line
The standard line contains high-quality hyaluronic acid in seven concentration and volume combinations. Product selection and administration regimen are determined by the physician based on clinical judgement.







Cross-linked HA
Highly purified bacterial-origin hyaluronic acid with a cross-linked structure. The manufacturer states one application per treatment cycle and an effect lasting up to 12 months.



Data and images are taken from the current BiosanBio manufacturer catalogues. The products are intended for use by appropriately trained healthcare professionals.
PHIBIO · FRANKFURTPhiBio GmbH · combination formula
A sterile viscoelastic gel for intra-articular use combines three ingredients in one pre-filled syringe: sodium hyaluronate, N-acetylglucosamine and chondroitin sulphate. ViscoPhi Trio complements the Remedica range as a standalone combination solution.
Contributes to the viscosity and elasticity of joint fluid, thereby supporting joint lubrication, load cushioning and easier movement.
A biological building block of glycosaminoglycans, molecules involved in cartilage matrix structure. Its role in the formula is supportive and does not imply proven cartilage regeneration.
Naturally present in cartilage tissue; its negatively charged chains bind water and contribute to cartilage flexibility and resistance to compression.
The product is intended for use by appropriately trained healthcare professionals. Data are taken from the manufacturer's documentation and the medical device register.
Company
2014—present
Remedica is a Slovenian company established in 2014. We distribute selected medical devices for orthopaedics, regenerative medicine and other specialist fields.
We supply products to healthcare institutions, private clinics and specialist practices. We provide our partners with professional guidance, product presentations by medically qualified staff and support tailored to the needs of their professional team.
Get in touch
Tell us what you need. Together, we will find the right solution for your institution or practice.
Send an enquiry Remedica d.o.o.Planinska cesta 37A, 6210 Sežanajure@remedica.siVAT ID: SI72308818Information for healthcare professionals. The products presented on this website are medical devices intended for use by appropriately trained healthcare professionals. The content is not intended for self-diagnosis or self-treatment.